Impact of thoracoabdominal imaging on diagnosis and management in patients with suspected infective endocarditis

Eur J Intern Med. 2023 Oct:116:82-88. doi: 10.1016/j.ejim.2023.06.007. Epub 2023 Jun 15.

Abstract

Background: Embolic events (EEs) are a common complication of infective endocarditis (IE) and their presence can impact diagnosis and modify the therapeutic plan. The present study aimed to describe the role of thoracoabdominal imaging, either thoracoabdominal-pelvic Computed Tomography or 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, on diagnosis and management of patients with suspected IE.

Methods: This study was conducted at a university hospital, from January 2014 to June 2022. EEs and IE were defined according to modified Duke criteria.

Results: Among 966 episodes with suspected IE and thoracoabdominal imaging, 528 (55%) patients were asymptomatic. At least one EE was found in 205 (21%) episodes. Based on thoracoabdominal imaging findings, the diagnosis was reclassified from rejected to possible or from possible to definite IE in 6 (1%) and 10 (1%) episodes, respectively. Among the 413 patients with IE, at least one EE was found on thoracoabdominal imaging in 143 (35%) episodes. Together with the presence of left-side valvular vegetation >10 mm, the results of thoracoabdominal imaging established a surgical indication (prevention of embolism) in 15 (4%) episodes, 7 of which were asymptomatic.

Conclusions: Thoracoabdominal imaging performed in asymptomatic patients with suspected IE improved the diagnosis in only a small proportion of patients. Thoracoabdominal imaging led to a new surgical indication (in association with left-side valvular vegetation >10 mm) in only a small percentage of patients.

Keywords: (18)F-FDG PET/CT; Acute kidney injury; CT scan; Embolization; Infective endocarditis.

MeSH terms

  • Endocarditis* / complications
  • Endocarditis* / diagnostic imaging
  • Endocarditis* / therapy
  • Endocarditis, Bacterial* / complications
  • Fluorodeoxyglucose F18
  • Humans
  • Positron Emission Tomography Computed Tomography / adverse effects
  • Positron Emission Tomography Computed Tomography / methods
  • Radiopharmaceuticals
  • Tomography, X-Ray Computed / adverse effects
  • Tomography, X-Ray Computed / methods

Substances

  • Fluorodeoxyglucose F18
  • Radiopharmaceuticals